These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15808487)

  • 21. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical kinetics for a series of putative dopamine antagonists to reverse the low-magnitude Ca2+ phase in the dopamine-bound D2short receptor state.
    Pauwels PJ; Koek W
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):82-5. PubMed ID: 11862337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
    Ramanathan S; Tkatch T; Atherton JF; Wilson CJ; Bevan MD
    J Neurophysiol; 2008 Feb; 99(2):442-59. PubMed ID: 18094105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide type.
    Norinder U; Högberg T
    Acta Pharm Nord; 1992; 4(2):73-8. PubMed ID: 1388772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones.
    Lee IT; Chen S; Schetz JA
    Eur J Pharmacol; 2008 Jan; 578(2-3):123-36. PubMed ID: 17961544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SAR of novel biarylmethylamine dopamine D4 receptor ligands.
    Arlt M; Böttcher H; Riethmüller A; Schneider G; Bartoszyk GD; Greiner H; Seyfried CA
    Bioorg Med Chem Lett; 1998 Aug; 8(15):2033-8. PubMed ID: 9873481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK
    Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists.
    Zhu Z; Sun ZY; Ye Y; McKittrick B; Greenlee W; Czarniecki M; Fawzi A; Zhang H; Lachowicz JE
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5218-21. PubMed ID: 19643610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
    Depoortère R; Barret-Grévoz C; Bardin L; Newman-Tancredi A
    Eur J Pharmacol; 2008 Nov; 597(1-3):34-8. PubMed ID: 18773888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictions of binding for dopamine D2 receptor antagonists by the SIE method.
    Wang YT; Su ZY; Hsieh CH; Chen CL
    J Chem Inf Model; 2009 Oct; 49(10):2369-75. PubMed ID: 19769359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure activity relationships (QSAR) of substituded (S)-phenylpiperidines as preferential dopamine autoreceptor antagonists.
    Pontiki EA; Hadjipavlou-Litina DJ; Demertzis AM; Hadjidakis I; Kovala-Demertzi D
    J Enzyme Inhib Med Chem; 2005 Feb; 20(1):5-12. PubMed ID: 15895678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN; Kapur S; Seeman P; Wilson AA
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands.
    Thurkauf A; Chen X; Zhang S; Gao Y; Kieltyka A; Wasley JW; Brodbeck R; Greenlee W; Ganguly A; Zhao H
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2921-4. PubMed ID: 14611858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new approach to finding specific dopamine D4 receptor agonists.
    Morishita H; Shibata K; Sakata N; Kita S; Katsuragi T
    Eur J Pharmacol; 2005 Jun; 516(2):145-50. PubMed ID: 15922324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of the clozapine structure by parallel synthesis.
    Su J; Tang H; McKittrick BA; Burnett DA; Zhang H; Smith-Torhan A; Fawzi A; Lachowicz J
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4548-53. PubMed ID: 16806922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
    J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    Bailey A; Metaxas A; Yoo JH; McGee T; Kitchen I
    Eur J Neurosci; 2008 Aug; 28(4):759-70. PubMed ID: 18671743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.